Financial results: Bioxyne; Rua Bioscience; Bod Science; Avecho; Wellnex Life; MGC Pharma; Cannasouth by Steve Jones March 7, 2024March 7, 2024 Bioxyne was hit with an impairment charge of A$11.5 million in the first half of FY24 […]
Company news: Cann Global; Cann Group; InhaleRx; AusCann; Wellnex Life; Neurotech; MGC Pharma; Stenocare by Martin Lane December 4, 2023December 8, 2023
Company news: MediCann Health; MGC Pharma; Bod Science by Martin Lane November 8, 2023November 8, 2023
Financial results: Avecho; Wellnex; Zelira; Emyria; Botanix; MGC Pharma; AusCann; Epsilon; Melodiol; Bioxyne by Martin Lane and Steve Jones September 4, 2023September 4, 2023
Former AusCann CEO joins MGC Pharma as non-executive director by Steve Jones June 5, 2023June 5, 2023
Company news: Little Green Pharma; MGC Pharma; Medlab Clinical; Creso Pharma by Martin Lane February 9, 2023February 9, 2023
Company news: Helius Therapeutics; Little Green Pharma; MGC Pharma; Incannex by Martin Lane and Steve Jones December 7, 2022December 7, 2022
ASX launches Agribusiness Index with aim to build A$100 billion industry by 2030 by Martin Lane June 1, 2022June 1, 2022